Here’s what you should know:
1. Boston Scientific’s sales increased 5.6 percent year-over-year on a reported basis. .
2. Boston Scientific reported adjusted earnings of $283 million or $0.20 per share.
3. Boston Scientific CEO Mike Mahoney said in a release, “Our global team is delivering strong performance as we continue to invest in a deep and innovative portfolio and expand into faster-growing markets.”
4. Boston Scientific’s endoscopy division increased its sales by $7 million year-over-year.
5. Concerning rest-of-year outlooks, Boston Scientific expects earnings between $8.98 billion and $9.01 billion or a growth of up to 8 percent.
More articles on gastroenterology:
Gastro Health adds Dr. Robert Kaplan — 4 insights
GI center to know: Concord Endoscopy
CapsoVision earns CE Mark for CapsoCam Plus — 3 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
